All stock lists
Unlock the score
Prenetics Global Ltd (NASDAQ:PRE)
HK · Delayed Price · Currency is USD
Consumer Defensive · Household & Personal Products
18.34+0.99 (+5.68%)
Market cap
$311M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 16, 2021
Website
Insider Score
/ 100
PRE Insider Score
Prenetics Global Ltd has a live Insider Score.
Scored on 5 qualifying trades from 2 insiders in the last 90 days.
Financial Health Score
Fair
From PRE’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $142.6M
- Net income
- -$67.6M
- Net margin
- -47.4%
Leverage20 / 20
Little or no net debt.
- Total debt
- $682K
- Cash
- $59.0M
- Debt / equity
- 0.01
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $147.7M
- Current liabilities
- $36.6M
- Current ratio
- 4.04
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$49.4M
- Free cash flow
- -$34.1M
- FCF margin
- -24.0%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 17.3M
- Share growth (1y)
- 30.3%
- Cash runway
- 14 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PRE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 46.49 M | 35.95 M | 36.56 M | 23.55 M | 17.68 M | 17.31 M |
| Revenue Growth (YoY) | 162.94 % | 107.68 % | 248.57 % | 202.84 % | 197.57 % | 169.95 % |
| Cost of Revenue | 16.29 M | 12.67 M | 14.82 M | 9.53 M | 10.39 M | 9.97 M |
| Gross Profit | 30.20 M | 23.28 M | 21.74 M | 14.02 M | 7.29 M | 7.34 M |
| SG&A Expense | 51.37 M | 31.55 M | 28.57 M | 19.41 M | 15.95 M | 15.87 M |
| R&D Expense | 757.00 K | 1.44 M | 743.00 K | 1.17 M | 1.21 M | 2.42 M |
| Operating Expenses | 52.12 M | 32.99 M | 34.13 M | 20.19 M | 17.35 M | 17.97 M |
| Operating Income | -21.92 M | -9.71 M | -12.39 M | -6.16 M | -10.06 M | -10.63 M |
| Pretax Income | -9.08 M | -27.31 M | -28.37 M | -6.78 M | -10.95 M | -11.07 M |
| Tax Provision | 5.00 K | 28.00 K | 43.00 K | 9.00 K | -33.00 K | -64.00 K |
| Net Income | -8.98 M | -23.10 M | -28.11 M | -7.41 M | -12.41 M | -10.39 M |
| EPS (Basic) | -0.52 | -1.36 | -1.75 | -0.53 | -0.94 | -0.80 |
| EPS (Diluted) | -0.52 | -1.36 | -1.75 | -0.53 | -0.94 | -0.80 |
| Shares Outstanding | 17.27 M | 16.98 M | 16.03 M | 13.90 M | 13.25 M | 13.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.